Sinphar Pharmaceutical financials at a glance

Year Year 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2023 2022 2024
Rev. Revenue
NT$1.41B NT$1.71B NT$1.64B NT$1.76B NT$1.81B NT$1.81B NT$1.82B NT$1.84B NT$2.09B NT$2.58B NT$2.64B NT$2.19B NT$2.13B NT$2.13B NT$2.22B NT$2.39B NT$2.39B NT$2.43B NT$2.96B NT$2.86B NT$0.00M
GM % Gross Margin %
44.99% 45.24% 42.35% 39.54% 37.39% 39.92% 38.09% 37.70% 37.09% 37.41% 41.01% 35.93% 37.02% 37.97% 37.25% 39.29% 36.66% 36.52% 36.92% 38.25% 0.00%
OM Operating Margin
9.36% 7.99% 2.51% 4.88% 3.48% 7.44% 5.34% 3.40% 6.05% 6.30% 5.46% -5.86% -6.66% -2.95% -5.38% -6.14% -5.12% -7.51% 9.75% 6.95% 0.00%
EPS Earnings Per Share
NT$0.66 NT$1.79 NT$0.97 NT$0.10 NT$0.10 NT$0.00
Div. Dividends
NT$0.00 NT$0.00 NT$0.00 NT$0.00 NT$0.00 NT$0.00 NT$0.00 NT$0.00 NT$0.00 NT$0.00 NT$0.00 NT$0.00 NT$0.00 NT$0.00 NT$0.00 NT$0.00 NT$0.00 NT$0.00 NT$0.00 NT$0.00 NT$0.00
PR % Payout Ratio %
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Sha. Shares
110.38m 122.93m 122.93m 122.93m 124.28m 137.46m 143.38m 144.73m 167.72m 167.72m 167.72m 167.72m 167.72m 167.72m 167.72m 167.72m 167.72m 167.72m 0m 167.72m 167.72m
OCF Operating Cash Flow
NT$174.81M NT$122.09M NT$166.57M NT$174.85M NT$271.01M NT$309.94M NT$261.49M NT$225.58M NT$164.45M NT$297.09M NT$148.58M NT$280.53M NT$87.18M NT$219.87M NT$79.50M NT$-79.49M NT$146.39M NT$135.54M NT$296.37M NT$425.30M NT$0.00M
FCF Free Cash Flow
NT$14.02M NT$-66.68M NT$-82.87M NT$-240.05M NT$37.76M NT$92.72M NT$-28.11M NT$-131.47M NT$-195.63M NT$-291.23M NT$-103.70M NT$-11.01M NT$-125.73M NT$56.48M NT$-169.52M NT$-247.18M NT$2.38M NT$-10.64M NT$47.00M NT$283.82M NT$0.00M
FCFS Free Cash Flow Per Share
NT$-0.31 NT$-0.74 NT$-0.71 NT$-1.96 NT$0.21 NT$0.68 NT$-0.22 NT$-0.92 NT$-1.26 NT$-0.95 NT$-0.87 NT$-0.78 NT$-0.82 NT$0.29 NT$-1.05 NT$-1.53 NT$-0.07 NT$-0.15 NT$-0.03 NT$1.62 NT$0.00